Entity

Time filter

Source Type

Phoenix, AZ, United States

Patent
Translational Genomics Research Institute | Date: 2013-07-05

The present invention provides methods and kits that may be used to detect and quantify the presence of


Patent
Translational Genomics Research Institute | Date: 2012-04-04

This invention provides a therapeutic target for pancreatic cancer. The invention further provides methods of screening of new therapeutic agents using the target. The invention also provides a pharmaceutical composition comprising fasudil or derivatives thereof for pancreatic cancer treatment, and a kit comprising such a pharmaceutical composition.


Patent
Translational Genomics Research Institute | Date: 2013-03-12

This disclosure provides a glioblastoma biomarker profile comprising glioblastoma associated genetic aberrations. The profile is indicative of a cellular and physiological characteristic of a sample from a subject. The disclosure further provides methods for profiling glioblastoma cellular and physiological characteristics including subtype, survival and drug response.


Patent
Translational Genomics Research Institute | Date: 2012-03-26

This disclosure provides a biomarker profile, which is linked to cancer cell chemo-resistance. The disclosure further provides methods of diagnosis and theranosis, and screening of new therapeutic agents using these biomarkers in the profile, and kits for employing these methods and compositions.


Patent
Translational Genomics Research Institute | Date: 2014-03-14

The invention encompasses methods and kits used in the identification of invasive glioblastoma based upon the expression of Akt1, Akt2, and Akt3. The methods and kits also allow prediction of disease outcome and staging of patients with regard to therapy.

Discover hidden collaborations